Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00198107 · ClinicalTrials.gov registry record · Phase 3
Evaluating the Effectiveness of Aripiprazole and D-Cycloserine to Treat Symptoms Associated With Autism
A Phase 3 study of Autistic Disorder, sponsored by Indiana University.
- Completed
- Registry status
- Phase 3
- Development phase
- 81
- Enrollment target
- 1
- Study location
NCT00198107 is a Phase 3 study of Autistic Disorder that has completed, run by Indiana University. The registered enrollment target is 81 participants, below the 111-participant average among 27 other Autistic Disorder trials with a reported enrollment target (27% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00198107, a Phase 3 study of Autistic Disorder, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 81 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will determine the effectiveness of aripiprazole and D-Cycloserine in treating symptoms associated with autism in children.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Aripiprazole
- DRUG D-cycloserine
Study Locations (1)
Indiana
- Riley Hospital for Children, Christian Sarkine Autism Treatment Center - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2005-09 |
| Est. Completion | 2011-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00198107
The ClinicalTrials.gov registry entry for NCT00198107 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 111-participant average among 27 other Autistic Disorder trials with a reported enrollment target (27% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Autistic Disorder appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT00198107 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT00198107 about?
NCT00198107 is a clinical study titled "Evaluating the Effectiveness of Aripiprazole and D-Cycloserine to Treat Symptoms Associated With Autism". This study will determine the effectiveness of aripiprazole and D-Cycloserine in treating symptoms associated with autism in children.
What is the current status of trial NCT00198107?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 81 participants. The study started on 2005-09. Estimated completion is 2011-09.
What conditions does trial NCT00198107 study?
This clinical trial studies the following conditions: Autistic Disorder.
What interventions are being tested in trial NCT00198107?
The interventions under investigation include: Placebo (DRUG), Aripiprazole (DRUG), D-cycloserine (DRUG).
Who is sponsoring clinical trial NCT00198107?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00198107 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autistic Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
D-Cycloserine and Social Skills Training in Autism Spectrum Disorders
COMPLETED · Phase 3
-
Study of Fluoxetine in Autism
COMPLETED · Phase 3
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism
RECRUITING
-
Telehealth Parent-Implemented Intervention for Young Children With Autism Spectrum Disorder (ASD)
RECRUITING · NA
-
Randomized Clinical Trial of TUNE In 3.0: A Social/Emotional Program for Adults With Autism Spectrum Disorder
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.